Angiotensin receptor antagonist therapy fails to reduce heart failure mortality

A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke.

Journal of the American Heart Association·2013

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

The American journal of medicine·2013

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.

The American journal of medicine·2013

Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.

Stroke·2013

Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.

Circulation. Heart failure·2013

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.

JAMA·2013

Mitral Regurgitation in Contemporary Practice: From Diagnosis to Management.

Reviews in cardiovascular medicine·2026

Effect of Intracoronary Recombinant Human Prourokinase on Myocardial Perfusion and Clinical Outcomes in STEMI Patients Undergoing Primary PCI: A Randomized Controlled Trial.

Reviews in cardiovascular medicine·2026

Analysis of Risk Factors and Development of a Diagnostic Model for Ischemia in Patients With Nonobstructive Coronary Artery Disease Based on Positron Emission Tomography/Computed Tomography.

Reviews in cardiovascular medicine·2026

Clinical Prognostic Impact of CALLY in Heart Failure Patients With Different Ejection Fractions: A Retrospective Study.

Reviews in cardiovascular medicine·2026

A Novel Selective Sinus Reinforcement Technique for Acute Type A Aortic Dissection Involving the Aortic Root.

Reviews in cardiovascular medicine·2026

Procedural Management of Atrial Fibrillation in Older Patients.

Reviews in cardiovascular medicine·2026

Sustained LDL-C target attainment and recurrent ischemic cerebrovascular events after ischemic stroke: effect modification by large-artery disease.

Frontiers in neurology·2026

c.1681-7 G>A Variant in the Factor XII Gene in a Family Diagnosed with HAE-FXII Does Not Affect Splice Site.

Pediatric allergy, immunology, and pulmonology·2026

Habenula as a Marker of Thalamic Asymmetrical Skew and a Landmark for the Vim-Vc Boundary in MRgFUS Thalamotomy.

Stereotactic and functional neurosurgery·2026

Retrograde Collateral Crossing Through Riolan's Arcade With Femoral Antegrade Reconstruction After Traction During Upper-Extremity Externalization.

JACC. Case reports·2026

Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: "First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level".

Haematologica·2026

Fibrinogen and leukemic-cell trafficking: possible implications for hyperleukocytosis and differentiation syndrome. Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".

Haematologica·2026

Related Experiment Videos

Angiotensin receptor antagonist therapy fails to reduce heart failure mortality

Related Concept Videos

A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke.

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.

Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.

Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.

Mitral Regurgitation in Contemporary Practice: From Diagnosis to Management.

Effect of Intracoronary Recombinant Human Prourokinase on Myocardial Perfusion and Clinical Outcomes in STEMI Patients Undergoing Primary PCI: A Randomized Controlled Trial.

Analysis of Risk Factors and Development of a Diagnostic Model for Ischemia in Patients With Nonobstructive Coronary Artery Disease Based on Positron Emission Tomography/Computed Tomography.

Clinical Prognostic Impact of CALLY in Heart Failure Patients With Different Ejection Fractions: A Retrospective Study.

A Novel Selective Sinus Reinforcement Technique for Acute Type A Aortic Dissection Involving the Aortic Root.

Procedural Management of Atrial Fibrillation in Older Patients.

Sustained LDL-C target attainment and recurrent ischemic cerebrovascular events after ischemic stroke: effect modification by large-artery disease.

c.1681-7 G>A Variant in the Factor XII Gene in a Family Diagnosed with HAE-FXII Does Not Affect Splice Site.

Habenula as a Marker of Thalamic Asymmetrical Skew and a Landmark for the Vim-Vc Boundary in MRgFUS Thalamotomy.

Retrograde Collateral Crossing Through Riolan's Arcade With Femoral Antegrade Reconstruction After Traction During Upper-Extremity Externalization.

Fibrinogen and leukemic-cell trafficking: possible implications for hyperleukocytosis and differentiation syndrome. Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".

Related Experiment Videos

Angiotensin receptor antagonist therapy fails to reduce heart failure mortality

Related Concept Videos

Related Articles